SCHEMBL6002565

SCHEMBL6002565

CC(C)Oc1cc(-c2cccc(O)c2)ccc1O

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 12/20 0.53
HSD17B2 P37059 12/20 0.53
CYP3A4 P08684 5/20 0.52
CYP2C9 P11712 3/20 0.52
PELI1 Q96FA3 1/20 0.45
CYP2D6 P10635 4/20 0.44
CYP2C19 P33261 4/20 0.44
ESR1 P03372 3/20 0.44
ESR2 Q92731 3/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2B6 P20813 2/20 0.44
KDM1A O60341 1/20 0.44
MAOA P21397 1/20 0.44
MKNK1 Q9BUB5 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
CYP17A1 P05093 1/20 0.43
FYN P06241 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7726674 0.80 MAOB (0.59) HSD17B1HSD17B2CYP2C9
SCHEMBL8469680 0.79 HSD17B1 (0.61) HSD17B1HSD17B2CYP3A4CYP2C9CYP2D6
SCHEMBL2095173 0.77 HSD17B1 (0.49) HSD17B1HSD17B2CYP3A4CYP2C9CYP2D6
SCHEMBL4601434 0.77 RXRA (0.50) HSD17B1HSD17B2CYP3A4CYP2C9MKNK1
SCHEMBL5687510 0.73 HSD17B1 (0.58) HSD17B1HSD17B2CYP3A4CYP2C9PELI1
SCHEMBL21002206 0.72 APP (0.77) HSD17B1HSD17B2CYP3A4CYP2C9PELI1
SCHEMBL7898375 0.71 HSD17B1 (1.00) HSD17B1HSD17B2CYP3A4CYP2C9CYP2D6
SCHEMBL12656410 0.71 HSD17B1 (0.96) HSD17B1HSD17B2CYP3A4CYP2C9CYP2D6
SCHEMBL13963701 0.71 PDE10A (0.48) HSD17B1HSD17B2CYP3A4CYP2C9CYP2C19
SCHEMBL29848168 0.71 HSD17B1 (0.96) HSD17B1HSD17B2CYP3A4CYP2C9CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed